Join
Live feed
·
PRReleasevia Quantisnow
Matinas Biopharma Holdings Inc. logo

Matinas BioPharma to Provide Corporate Update and 2022 Business Outlook on January 25, 2022

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MTNB (Matinas Biopharma Holdings Inc.) and more on Quantisnow.